Resistance to Trastuzumab.

Cancers (Basel) · 2022 · PMC9600208 · PMID 36291900

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

As indicated by Hunter et al., there are likely to be significant differences in resistance mechanisms between trastuzumab and TDM-1, given the pre-eminence of the DM-1-mediated effects of the ADC [ 219 ].

also in 1,824 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.